A Conversation with Geisinger Health System's David Ledbetter at ACMG

BioArray News editor Justin Petrone caught up with David Ledbetter, CSO of Geisinger Health System, at the recent Annual Clinical Genetics Meeting held in Charlotte, NC, to discuss the future of CMA as a first-tier test, classifying findings of uncertain significance, and more.

Other Genomeweb Videos

For Even More Videos Click Here

For Even More Videos Click Here